In the News

ViaCyte Receives Clearance from Health Canada for Diabetes Clinical Trial
By JDRF Canada
January 9, 2015

ViaCyte, Inc., a privately-held regenerative medicine company with the first stem cell-derived islet replacement therapy for the treatment of diabetes in clinical trials, has received a No Objection Letter from Health Canada providing clearance to proceed with sites in Canada for the Company's Phase 1/2 clinical trial of its VC-01TM product candidate.

Read More
Tags: ViaCyte, Health Canada, Clinical Trials
Major Milestone in Communications Standards for Diabetes Devices
By JDRF Canada
December 11, 2014

JDRF-funded program at the Centre for Global eHealth Innovation establishes open communication standards to enhance diabetes management and accelerate artificial pancreas research

Read More
JDRF in the Globe and Mail, November 25, 2014: For kids, research and new treatment options bring less discomfort and better outcomes
By JDRF Canada
November 26, 2014

JDRF showcases advancements in CGM technology in making monitoring of glucose levels better and the new experimental encapsulated cell replacement therapy.

Read More
Tags: Avery Rice, JDRF, NDAM, CGM, encapsulated cell replacement therapy, Globe and Mail, article
40 Kids and Country Superstar George Canyon Step up to Cure Type 1 Diabetes
By JDRF Canada
November 25, 2014

40 Kids and Country Superstar George Canyon Step up to Cure Type 1 Diabetes (T1D)
JDRF Ambassadors head to Parliament Hill to discuss the importance of funding research

Read More
Tags: Canadian Post-doctoral Fellowships, Research, Lilly Canada, JDRF, T1D
JDRF On Canada AM
By JDRF Canada
November 17, 2014

Dave Prowten and JDRF Youth Ambassador discuss Kids for a Cure Awareness Day with CTV Canada AM on Nov. 14

Read More